Greenleaf Trust Davita Inc. Transaction History

Greenleaf Trust

$11.2 Billion
Q3 2024

A detailed history of Greenleaf Trust transactions in Davita Inc. stock. As of the latest transaction made, Greenleaf Trust holds 1,897 shares of DVA stock, worth $313,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,897

Previous 1,903 0.32%

Holding current value

$313,972

Previous $263,000 17.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$133.98 - $165.19 $803 - $991	-6 Reduced 0.32%	1,897 $310,000
Q2 2024 Jul 22, 2024	BUY	$126.11 - $147.14 $1,513 - $1,765	12 Added 0.63%	1,903 $263,000
Q1 2024 Apr 29, 2024	BUY	$103.89 - $139.21 $196,455 - $263,246	1,891 New	1,891 $261,000
Q2 2023 Aug 09, 2023	BUY	$81.58 - $100.93 $167,973 - $207,814	2,059 New	2,059 $206,000
Q2 2022 Aug 12, 2022	SELL	$76.05 - $123.38 $217,655 - $353,113	-2,862 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$108.37 - $120.0 $433 - $480	4 Added 0.14%	2,862 $324,000
Q4 2021 Feb 11, 2022	SELL	$94.5 - $116.95 $68,229 - $84,437	-722 Reduced 20.17%	2,858 $325,000
Q3 2021 Nov 12, 2021	BUY	$116.26 - $133.78 $33,947 - $39,063	292 Added 8.88%	3,580 $416,000
Q2 2021 Aug 10, 2021	BUY	$105.44 - $127.98 $3,268 - $3,967	31 Added 0.95%	3,288 $396,000
Q1 2021 Apr 30, 2021	BUY	$99.98 - $123.89 $5,198 - $6,442	52 Added 1.62%	3,257 $351,000
Q4 2020 Feb 08, 2021	BUY	$82.82 - $117.4 $1,573 - $2,230	19 Added 0.6%	3,205 $376,000
Q3 2020 Oct 30, 2020	BUY	$79.57 - $91.84 $5,172 - $5,969	65 Added 2.08%	3,186 $273,000
Q2 2020 Aug 12, 2020	BUY	$65.52 - $88.28 $204,487 - $275,521	3,121 New	3,121 $247,000

Others Institutions Holding DVA

# of Institutions

662

Shares Held

74.4M

Call Options Held

1.41M

Put Options Held

1.82M

View Full List

About DAVITA INC.

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $15.1B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

More about DVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account